Oxygen radical-induced inhibition of alkaline phosphatase activity in reconstituted membranes.
The effects of lipid peroxidation on membrane-bound enzyme activity were examined using reconstituted membranes consisting of intestinal alkaline phosphatase (ALP) and phosphatidylcholine (PC) or dipalmitoylphosphatidylcholine (DPPC). When the PC-reconstituted membranes were incubated with ascorbic acid/Fe2+, the ALP activity decreased with increases in the thiobarbituric acid-reactive substances and conjugated diene values in a time-dependent manner. The kinetic studies on the ALP activity with varying the p-nitrophenyl phosphate or beta-glycerophosphate concentrations showed that the inhibition of the enzyme activity by treatment with these oxidizing agents is mainly due to a decrease in the Vmax value rather than a change in the Km value. The results with several antioxidants suggested that ascorbic acid/Fe(2+)-induced inhibition of the ALP activity is related to generation of .OH radicals. Modification of the reconstituted membranes with malondialdehyde, trans-2-nonenal, or n-heptaldehyde did not affect the ALP activity, suggesting that the secondary degraded products of lipid hydroperoxides had no influence on the enzyme activity. Increasing bityrosine production in the membrane constituents was observed by ascorbic acid/Fe2+ treatment, depending on the incubation time. This finding suggests the possibility that amino acid modifications in the protein molecule are induced by the treatment. Furthermore, the contribution of the lipid organization in ascorbic acid/Fe(2+)-induced inhibition of the ALP activity in the reconstituted membranes was examined by measurements of the fluorescence anisotropy of diphenylhexatriene-labeled membranes. In addition, it was found that the ALP activity in DPPC-reconstituted membranes was also inhibited by treatment with ascorbic acid/Fe2+, similar to the case in PC-reconstituted ones. On the basis of these results, a possible mechanism of ascorbic acid/Fe(2+)-induced inhibition of membrane-bound ALP activity is discussed.
Ohyashiki
T
T
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokuriku University, Ishikawa, Japan.
Kumada
Y
Y
Hatanaka
N
N
Matsui
K
K
D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D004134:Dimyristoylphosphatidylcholine / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000201:enzymology; D007700:Kinetics; D015227:Lipid Peroxidation; D008081:Liposomes; D008560:Membrane Fluidity; D010713:Phosphatidylcholines / Q000494:pharmacology*; D013050:Spectrometry, Fluorescence; D013481:Superoxides / Q000494:pharmacology*; D013552:Swine
D000975:Antioxidants; D008081:Liposomes; D010713:Phosphatidylcholines; D013481:Superoxides; D000469:Alkaline Phosphatase; D004134:Dimyristoylphosphatidylcholine